Literature DB >> 12119219

Granulocyte macrophage-colony stimulating factor augmentation therapy in sepsis: is there a role?

Bruce C Trapnell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12119219     DOI： 10.1164/rccm.2205017

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  5 in total

1.  Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis.

Authors:  Axel Nierhaus; Barbara Montag; Nicole Timmler; Daniel P Frings; Kai Gutensohn; Roman Jung; Claus G Schneider; Werner Pothmann; Anne K Brassel; Jochen Schulte Am Esch
Journal:  Intensive Care Med       Date:  2003-02-21       Impact factor: 17.440

2.  Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis.

Authors:  Jacek Szeliga; D Sundarsingh Daniel; Ching-Hui Yang; Zvjezdana Sever-Chroneos; Chinnaswamy Jagannath; Zissis C Chroneos
Journal:  Tuberculosis (Edinb)       Date:  2007-10-24       Impact factor: 3.131

3.  HIV-1-transgene expression in rats decreases alveolar macrophage zinc levels and phagocytosis.

Authors:  Pratibha C Joshi; Robert Raynor; Xian Fan; David M Guidot
Journal:  Am J Respir Cell Mol Biol       Date:  2008-02-28       Impact factor: 6.914

4.  A murine model of hereditary pulmonary alveolar proteinosis caused by homozygous Csf2ra gene disruption.

Authors:  Kenjiro Shima; Paritha Arumugam; Anthony Sallese; Yuko Horio; Yan Ma; Cole Trapnell; Matthew Wessendarp; Claudia Chalk; Cormac McCarthy; Brenna C Carey; Bruce C Trapnell; Takuji Suzuki
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-01-19       Impact factor: 5.464

5.  Pulmonary alveolar proteinosis: An autoimmune disease lacking an HLA association.

Authors:  Kirsten Anderson; Brenna Carey; Allison Martin; Christina Roark; Claudia Chalk; Marchele Nowell-Bostic; Brian Freed; Michael Aubrey; Bruce Trapnell; Andrew Fontenot
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.